Moreover, KLF4 can enhance the sensitivity of colon cancer cells to cisplatin through altering the expression of HMGB1 (high-mobility group box 1) and hTERT (human telomerase reverse transcriptase) 14. Here, KLF4 is linked to colonic neoplasm.